QbD enabled optimization of solvent shifting method for fabrication of PLGA-based nanoparticles for promising delivery of Capecitabine for antitumor activity

[1]  C. Patra,et al.  Cytotoxicity and Pharmacokinetic Studies of PLGA Based Capecitabine Loaded Nanoparticles , 2020 .

[2]  I. Yaylim,et al.  Silver nanoparticle/capecitabine for breast cancer cell treatment. , 2019, Toxicology in vitro : an international journal published in association with BIBRA.

[3]  B. Mishra,et al.  Assessing the viability of Soluplus® self-assembled nanocolloids for sustained delivery of highly hydrophobic lapatinib (anticancer agent): Optimisation and in-vitro characterisation. , 2019, Colloids and surfaces. B, Biointerfaces.

[4]  M. Eroglu,et al.  Development and optimization of a novel PLGA-Levan based drug delivery system for curcumin, using a quality-by-design approach. , 2019, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[5]  A. Tyagi,et al.  Nose-to-brain delivery of lamotrigine-loaded PLGA nanoparticles , 2019, Drug Delivery and Translational Research.

[6]  S. Jeong,et al.  Development of sorafenib loaded nanoparticles to improve oral bioavailability using a quality by design approach. , 2019, International journal of pharmaceutics.

[7]  C. Patra,et al.  Quality by Design Enabled Development of Oral Self-Nanoemulsifying Drug Delivery System of a Novel Calcimimetic Cinacalcet HCl Using a Porous Carrier: In Vitro and In Vivo Characterisation , 2019, AAPS PharmSciTech.

[8]  K. Karimian,et al.  Capecitabine-loaded nanoniosomes and evaluation of anticancer efficacy , 2019, Artificial cells, nanomedicine, and biotechnology.

[9]  C. Patra,et al.  QBD-based systematic development of Bosentan SNEDDS: Formulation, characterization and pharmacokinetic assessment , 2018, Journal of Drug Delivery Science and Technology.

[10]  C. Sharma,et al.  Eudragit encapsulated cationic poly (lactic-co-glycolic acid) nanoparticles in targeted delivery of capecitabine for augmented colon carcinoma therapy , 2018, Journal of Drug Delivery Science and Technology.

[11]  N. Dudhipala,et al.  Capecitabine lipid nanoparticles for anti-colon cancer activity in 1,2-dimethylhydrazine-induced colon cancer: preparation, cytotoxic, pharmacokinetic, and pathological evaluation , 2018, Drug development and industrial pharmacy.

[12]  J. Hou,et al.  A novel high drug loading mussel-inspired polydopamine hybrid nanoparticle as a pH-sensitive vehicle for drug delivery. , 2017, International journal of pharmaceutics.

[13]  Bhupinder Singh Bhoop,et al.  Supramolecular nano-engineered lipidic carriers based on diflunisal-phospholipid complex for transdermal delivery: QbD based optimization, characterization and preclinical investigations for management of rheumatoid arthritis. , 2017, International journal of pharmaceutics.

[14]  B. D. Rohera,et al.  An integrated, quality by design (QbD) approach for design, development and optimization of orally disintegrating tablet formulation of carbamazepine , 2017, Pharmaceutical development and technology.

[15]  Xiaohong Liu,et al.  Characterization and cytotoxicity of PLGA nanoparticles loaded with formononetin cyclodextrin complex , 2017 .

[16]  Kiran Karande,et al.  Optimization of desolvation process for fabrication of lactoferrin nanoparticles using quality by design approach , 2017, Artificial cells, nanomedicine, and biotechnology.

[17]  M. Khan,et al.  A small variation in average particle size of PLGA nanoparticles prepared by nanoprecipitation leads to considerable change in nanoparticles’ characteristics and efficacy of intracellular delivery , 2017, Artificial cells, nanomedicine, and biotechnology.

[18]  L. Kumar,et al.  A quality by design approach on polymeric nanocarrier delivery of gefitinib: formulation, in vitro, and in vivo characterization , 2016, International journal of nanomedicine.

[19]  B. Ramírez-Wong,et al.  Nano- and Micro-Particles by Nanoprecipitation: Possible Application in the Food and Agricultural Industries , 2016 .

[20]  S. Singh,et al.  Development of zolmitriptan loaded PLGA/poloxamer nanoparticles for migraine using quality by design approach. , 2016, International journal of biological macromolecules.

[21]  Buket Aksu,et al.  Quality by design case study 1: Design of 5-fluorouracil loaded lipid nanoparticles by the W/O/W double emulsion - Solvent evaporation method. , 2016, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[22]  R. Tyagi,et al.  Nanostructured lipid carrier mediates effective delivery of methotrexate to induce apoptosis of rheumatoid arthritis via NF-κB and FOXO1. , 2016, International journal of pharmaceutics.

[23]  Bhupinder Singh,et al.  QbD-enabled systematic development of gastroretentive multiple-unit microballoons of itopride hydrochloride , 2016, Drug delivery.

[24]  Praveen Kumar,et al.  Development and In Vitro Characterization of Capecitabine-Loaded Alginate–Pectinate–Chitosan Beads for Colon Targeting , 2016 .

[25]  A. Mehrotra,et al.  Preparation and Characterization and Biodistribution Studies of Lomustine Loaded PLGA Nanoparticles by Interfacial Deposition Method , 2015 .

[26]  S. Suresh,et al.  Development of Novel Docetaxel Phospholipid Nanoparticles for Intravenous Administration: Quality by Design Approach , 2015, AAPS PharmSciTech.

[27]  A. Alshamsan.  Nanoprecipitation is more efficient than emulsion solvent evaporation method to encapsulate cucurbitacin I in PLGA nanoparticles. , 2014, Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society.

[28]  P. S. Rajinikanth,et al.  Formulation and delivery of itraconazole to the brain using a nanolipid carrier system , 2014, International journal of nanomedicine.

[29]  Ergun Karaagaoglu,et al.  Development and evaluation of paclitaxel nanoparticles using a quality-by-design approach. , 2013, Journal of pharmaceutical sciences.

[30]  M. Qiao,et al.  Preparation, characterization, cellular uptake and evaluation in vivo of solid lipid nanoparticles loaded with cucurbitacin B , 2013, Drug development and industrial pharmacy.

[31]  Min-Soo Kim,et al.  Quality by design: screening of critical variables and formulation optimization of Eudragit E nanoparticles containing dutasteride , 2013, Archives of pharmacal research.

[32]  R. Cormack,et al.  Facile synthesis of PEGylated PLGA nanoparticles encapsulating doxorubicin and its in vitro evaluation as potent drug delivery vehicle , 2013, Drug Delivery and Translational Research.

[33]  K. Griebenow,et al.  Two-step nanoprecipitation for the production of protein-loaded PLGA nanospheres , 2012, Results in pharma sciences.

[34]  Guoqiang Jiang,et al.  Preparation and evaluation of paclitaxel-loaded nanoparticle incorporated with galactose-carrying polymer for hepatocyte targeted delivery , 2012, Drug development and industrial pharmacy.

[35]  Amit Jain,et al.  Cyclosporin A Loaded PLGA Nanoparticle: Preparation, Optimization, In-Vitro Characterization and Stability Studies , 2010 .

[36]  M. Morishita,et al.  Encapsulation of hydrophilic and lipophilic drugs in PLGA nanoparticles by the nanoprecipitation method. , 1999, Drug development and industrial pharmacy.

[37]  Svetlana Ibrić,et al.  Quality-by-design in pharmaceutical development , 2013 .